ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgen Receptor (AR) Antagonist Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-29W17150
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Androgen Receptor AR Antagonist Market Research Report 2024
BUY CHAPTERS

Global Androgen Receptor (AR) Antagonist Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-29W17150
Report
October 2025
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
R&D Systems
Bayer
Janssen Pharmaceuticals
Pfizer Inc
Astellas Pharma
Hengrui Medicine
Kaituo Pharmaceutical
R&D Systems

Androgen Receptor (AR) Antagonist Market

The global Androgen Receptor (AR) Antagonist market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Androgen receptor (AR) antagonists are a class of drugs that bind to androgen receptors, thereby preventing or reducing the biological effects of androgens.
From a downstream perspective, Prostate Cancer accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Androgen Receptor (AR) Antagonist leading manufacturers including R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine, etc., dominate supply; the top five capture approximately % of global revenue, with R&D Systems leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Androgen Receptor (AR) Antagonist market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Androgen Receptor (AR) Antagonist Market Report

Report Metric Details
Report Name Androgen Receptor (AR) Antagonist Market
Segment by Type
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Androgen Receptor (AR) Antagonist study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Androgen Receptor (AR) Antagonist Market report?

Ans: The main players in the Androgen Receptor (AR) Antagonist Market are R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine

What are the Application segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Applications covered in the Androgen Receptor (AR) Antagonist Market report are Prostate Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Types covered in the Androgen Receptor (AR) Antagonist Market report are Steroidal AR Antagonists, Nonsteroidal AR Antagonists

Recommended Reports

Prostate Cancer Markets

Receptor Antagonist Drugs

Hormone and Urology Therapies

1 Study Coverage
1.1 Introduction to Androgen Receptor (AR) Antagonist: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Androgen Receptor (AR) Antagonist Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Steroidal AR Antagonists
1.2.3 Nonsteroidal AR Antagonists
1.3 Market Segmentation by Application
1.3.1 Global Androgen Receptor (AR) Antagonist Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Androgen Receptor (AR) Antagonist Revenue Estimates and Forecasts 2020-2031
2.2 Global Androgen Receptor (AR) Antagonist Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Androgen Receptor (AR) Antagonist Sales Estimates and Forecasts 2020-2031
2.4 Global Androgen Receptor (AR) Antagonist Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Androgen Receptor (AR) Antagonist Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Androgen Receptor (AR) Antagonist Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Steroidal AR Antagonists Market Size by Manufacturers
3.5.2 Nonsteroidal AR Antagonists Market Size by Manufacturers
3.6 Global Androgen Receptor (AR) Antagonist Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Androgen Receptor (AR) Antagonist Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Androgen Receptor (AR) Antagonist Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Androgen Receptor (AR) Antagonist Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Androgen Receptor (AR) Antagonist Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Androgen Receptor (AR) Antagonist Sales and Revenue by Type (2020-2031)
6.4 North America Androgen Receptor (AR) Antagonist Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Androgen Receptor (AR) Antagonist Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Androgen Receptor (AR) Antagonist Sales and Revenue by Type (2020-2031)
7.4 Europe Androgen Receptor (AR) Antagonist Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Androgen Receptor (AR) Antagonist Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Androgen Receptor (AR) Antagonist Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Androgen Receptor (AR) Antagonist Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Androgen Receptor (AR) Antagonist Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Androgen Receptor (AR) Antagonist Sales and Revenue by Type (2020-2031)
9.4 Central and South America Androgen Receptor (AR) Antagonist Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Androgen Receptor (AR) Antagonist Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Androgen Receptor (AR) Antagonist Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Androgen Receptor (AR) Antagonist Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 R&D Systems
11.1.1 R&D Systems Corporation Information
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.1.4 R&D Systems Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 R&D Systems Androgen Receptor (AR) Antagonist Sales by Product in 2024
11.1.6 R&D Systems Androgen Receptor (AR) Antagonist Sales by Application in 2024
11.1.7 R&D Systems Androgen Receptor (AR) Antagonist Sales by Geographic Area in 2024
11.1.8 R&D Systems Androgen Receptor (AR) Antagonist SWOT Analysis
11.1.9 R&D Systems Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Business Overview
11.2.3 Bayer Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.2.4 Bayer Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bayer Androgen Receptor (AR) Antagonist Sales by Product in 2024
11.2.6 Bayer Androgen Receptor (AR) Antagonist Sales by Application in 2024
11.2.7 Bayer Androgen Receptor (AR) Antagonist Sales by Geographic Area in 2024
11.2.8 Bayer Androgen Receptor (AR) Antagonist SWOT Analysis
11.2.9 Bayer Recent Developments
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Corporation Information
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.3.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales by Product in 2024
11.3.6 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales by Application in 2024
11.3.7 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales by Geographic Area in 2024
11.3.8 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist SWOT Analysis
11.3.9 Janssen Pharmaceuticals Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.4.4 Pfizer Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Pfizer Androgen Receptor (AR) Antagonist Sales by Product in 2024
11.4.6 Pfizer Androgen Receptor (AR) Antagonist Sales by Application in 2024
11.4.7 Pfizer Androgen Receptor (AR) Antagonist Sales by Geographic Area in 2024
11.4.8 Pfizer Androgen Receptor (AR) Antagonist SWOT Analysis
11.4.9 Pfizer Recent Developments
11.5 Astellas Pharma
11.5.1 Astellas Pharma Corporation Information
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.5.4 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Astellas Pharma Androgen Receptor (AR) Antagonist Sales by Product in 2024
11.5.6 Astellas Pharma Androgen Receptor (AR) Antagonist Sales by Application in 2024
11.5.7 Astellas Pharma Androgen Receptor (AR) Antagonist Sales by Geographic Area in 2024
11.5.8 Astellas Pharma Androgen Receptor (AR) Antagonist SWOT Analysis
11.5.9 Astellas Pharma Recent Developments
11.6 Kaituo Pharmaceutical
11.6.1 Kaituo Pharmaceutical Corporation Information
11.6.2 Kaituo Pharmaceutical Business Overview
11.6.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.6.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Kaituo Pharmaceutical Recent Developments
11.7 Hengrui Medicine
11.7.1 Hengrui Medicine Corporation Information
11.7.2 Hengrui Medicine Business Overview
11.7.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Models, Descriptions and Specifications
11.7.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hengrui Medicine Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Androgen Receptor (AR) Antagonist Industry Chain
12.2 Androgen Receptor (AR) Antagonist Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Androgen Receptor (AR) Antagonist Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Androgen Receptor (AR) Antagonist Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Androgen Receptor (AR) Antagonist Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Androgen Receptor (AR) Antagonist Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
R&D Systems
Bayer
Janssen Pharmaceuticals
Pfizer Inc
Astellas Pharma
Hengrui Medicine
Kaituo Pharmaceutical
R&D Systems
List of Tables
 Table 1. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Androgen Receptor (AR) Antagonist Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Androgen Receptor (AR) Antagonist Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Androgen Receptor (AR) Antagonist Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Androgen Receptor (AR) Antagonist Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Androgen Receptor (AR) Antagonist Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Androgen Receptor (AR) Antagonist Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 11. Global Androgen Receptor (AR) Antagonist Sales Share by Manufacturers (2020-2025)
 Table 12. Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Androgen Receptor (AR) Antagonist by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Receptor (AR) Antagonist as of 2024)
 Table 16. Global Androgen Receptor (AR) Antagonist Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Androgen Receptor (AR) Antagonist Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Androgen Receptor (AR) Antagonist Manufacturing Base and Headquarters
 Table 19. Global Androgen Receptor (AR) Antagonist Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Androgen Receptor (AR) Antagonist Sales by Type (2020-2025) & (Kilotons)
 Table 23. Global Androgen Receptor (AR) Antagonist Sales by Type (2026-2031) & (Kilotons)
 Table 24. Global Androgen Receptor (AR) Antagonist Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Androgen Receptor (AR) Antagonist Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Androgen Receptor (AR) Antagonist ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Androgen Receptor (AR) Antagonist Sales by Application (2020-2025) & (Kilotons)
 Table 29. Global Androgen Receptor (AR) Antagonist Sales by Application (2026-2031) & (Kilotons)
 Table 30. Androgen Receptor (AR) Antagonist High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Androgen Receptor (AR) Antagonist Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Androgen Receptor (AR) Antagonist Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Androgen Receptor (AR) Antagonist ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Androgen Receptor (AR) Antagonist Growth Accelerators and Market Barriers
 Table 37. North America Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Androgen Receptor (AR) Antagonist Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Androgen Receptor (AR) Antagonist Growth Accelerators and Market Barriers
 Table 40. Europe Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Androgen Receptor (AR) Antagonist Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Androgen Receptor (AR) Antagonist Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Androgen Receptor (AR) Antagonist Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Androgen Receptor (AR) Antagonist Investment Opportunities and Key Challenges
 Table 47. Central and South America Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Androgen Receptor (AR) Antagonist Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. R&D Systems Corporation Information
 Table 51. R&D Systems Description and Major Businesses
 Table 52. R&D Systems Product Models, Descriptions and Specifications
 Table 53. R&D Systems Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. R&D Systems Sales Value Proportion by Product in 2024
 Table 55. R&D Systems Sales Value Proportion by Application in 2024
 Table 56. R&D Systems Sales Value Proportion by Geographic Area in 2024
 Table 57. R&D Systems Androgen Receptor (AR) Antagonist SWOT Analysis
 Table 58. R&D Systems Recent Developments
 Table 59. Bayer Corporation Information
 Table 60. Bayer Description and Major Businesses
 Table 61. Bayer Product Models, Descriptions and Specifications
 Table 62. Bayer Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Bayer Sales Value Proportion by Product in 2024
 Table 64. Bayer Sales Value Proportion by Application in 2024
 Table 65. Bayer Sales Value Proportion by Geographic Area in 2024
 Table 66. Bayer Androgen Receptor (AR) Antagonist SWOT Analysis
 Table 67. Bayer Recent Developments
 Table 68. Janssen Pharmaceuticals Corporation Information
 Table 69. Janssen Pharmaceuticals Description and Major Businesses
 Table 70. Janssen Pharmaceuticals Product Models, Descriptions and Specifications
 Table 71. Janssen Pharmaceuticals Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. Janssen Pharmaceuticals Sales Value Proportion by Product in 2024
 Table 73. Janssen Pharmaceuticals Sales Value Proportion by Application in 2024
 Table 74. Janssen Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
 Table 75. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist SWOT Analysis
 Table 76. Janssen Pharmaceuticals Recent Developments
 Table 77. Pfizer Corporation Information
 Table 78. Pfizer Description and Major Businesses
 Table 79. Pfizer Product Models, Descriptions and Specifications
 Table 80. Pfizer Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. Pfizer Sales Value Proportion by Product in 2024
 Table 82. Pfizer Sales Value Proportion by Application in 2024
 Table 83. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 84. Pfizer Androgen Receptor (AR) Antagonist SWOT Analysis
 Table 85. Pfizer Recent Developments
 Table 86. Astellas Pharma Corporation Information
 Table 87. Astellas Pharma Description and Major Businesses
 Table 88. Astellas Pharma Product Models, Descriptions and Specifications
 Table 89. Astellas Pharma Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Astellas Pharma Sales Value Proportion by Product in 2024
 Table 91. Astellas Pharma Sales Value Proportion by Application in 2024
 Table 92. Astellas Pharma Sales Value Proportion by Geographic Area in 2024
 Table 93. Astellas Pharma Androgen Receptor (AR) Antagonist SWOT Analysis
 Table 94. Astellas Pharma Recent Developments
 Table 95. Kaituo Pharmaceutical Corporation Information
 Table 96. Kaituo Pharmaceutical Description and Major Businesses
 Table 97. Kaituo Pharmaceutical Product Models, Descriptions and Specifications
 Table 98. Kaituo Pharmaceutical Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. Kaituo Pharmaceutical Recent Developments
 Table 100. Hengrui Medicine Corporation Information
 Table 101. Hengrui Medicine Description and Major Businesses
 Table 102. Hengrui Medicine Product Models, Descriptions and Specifications
 Table 103. Hengrui Medicine Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 104. Hengrui Medicine Recent Developments
 Table 105. Key Raw Materials Distribution
 Table 106. Raw Materials Key Suppliers
 Table 107. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 108. Milestones in Production Technology Evolution
 Table 109. Distributors List
 Table 110. Market Trends and Market Evolution
 Table 111. Market Drivers and Opportunities
 Table 112. Market Challenges, Risks, and Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources


List of Figures
 Figure 1. Androgen Receptor (AR) Antagonist Product Picture
 Figure 2. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Steroidal AR Antagonists Product Picture
 Figure 4. Nonsteroidal AR Antagonists Product Picture
 Figure 5. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Prostate Cancer
 Figure 7. Breast Cancer
 Figure 8. Others
 Figure 9. Androgen Receptor (AR) Antagonist Report Years Considered
 Figure 10. Global Androgen Receptor (AR) Antagonist Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Androgen Receptor (AR) Antagonist Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2020-2031)
 Figure 14. Global Androgen Receptor (AR) Antagonist Sales (2020-2031) & (Kilotons)
 Figure 15. Global Androgen Receptor (AR) Antagonist Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 16. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Androgen Receptor (AR) Antagonist Sales Volume Market Share in 2024
 Figure 18. Global Androgen Receptor (AR) Antagonist Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Steroidal AR Antagonists Revenue Market Share by Manufacturer in 2024
 Figure 21. Nonsteroidal AR Antagonists Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2020-2031)
 Figure 23. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2020-2031)
 Figure 24. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2020-2031)
 Figure 25. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2020-2031)
 Figure 26. North America Androgen Receptor (AR) Antagonist Sales YoY (2020-2031) & (Kilotons)
 Figure 27. North America Androgen Receptor (AR) Antagonist Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) in 2024
 Figure 29. North America Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 30. North America Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Application (2020-2031)
 Figure 32. North America Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Androgen Receptor (AR) Antagonist Sales YoY (2020-2031) & (Kilotons)
 Figure 37. Europe Androgen Receptor (AR) Antagonist Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Type (2020-2031)
 Figure 40. Europe Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Application (2020-2031)
 Figure 42. Europe Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 44. France Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Androgen Receptor (AR) Antagonist Sales YoY (2020-2031) & (Kilotons)
 Figure 49. Asia-Pacific Androgen Receptor (AR) Antagonist Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 52. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Application (2020-2031)
 Figure 54. Asia-Pacific Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 59. India Androgen Receptor (AR) Antagonist Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Androgen Receptor (AR) Antagonist Sales YoY (2020-2031) & (Kilotons)
 Figure 61. Central and South America Androgen Receptor (AR) Antagonist Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Type (2021-2031)
 Figure 64. Central and South America Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Application (2020-2031)
 Figure 66. Central and South America Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Androgen Receptor (AR) Antagonist Sales YoY (2020-2031) & (Kilotons)
 Figure 70. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Type (2021-2031)
 Figure 73. South America Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Volume (Kilotons) by Application (2020-2031)
 Figure 75. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Androgen Receptor (AR) Antagonist Revenue (2020-2025) & (US$ Million)
 Figure 80. Androgen Receptor (AR) Antagonist Industry Chain Mapping
 Figure 81. Regional Androgen Receptor (AR) Antagonist Manufacturing Base Distribution (%)
 Figure 82. Global Androgen Receptor (AR) Antagonist Production Market Share by Region (2020-2031)
 Figure 83. Androgen Receptor (AR) Antagonist Production Process
 Figure 84. Regional Androgen Receptor (AR) Antagonist Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Androgen Receptor AR Inhibitor Market Research Report 2025
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global α adrenoreceptor Antagonists Market Research Report 2024
Global α blocker Market Research Report 2024
Global GnRH Receptor Antagonists Market Research Report 2024
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Purinergic Receptor Antagonists Market Research Report 2024
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AT1 Receptor Antagonists Market Research Report 2024
Global Androgen Antagonist Market Insights Forecast to 2030
Global Alpha Blockers Market Research Report 2024
Global IL 23 Receptor Antagonist Market Research Report 2024
Global 5 HT Receptor Antagonist Market Research Report 2025
Global Aldosterone Receptor Antagonists Market Research Report 2024
Global Androgen Antibody Market Research Report 2024
Global Androgen Receptor Antagonist Market Research Report 2024
Global Melanocortin Receptor Agonist Drugs Market Research Report 2024
Global Estrogen Receptor Modulators Market Research Report 2024
Global Selective Estrogen Receptor Modulators Market Research Report 2024
Global Enzalutamide API Market

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions